Drug combo could reduce risk of severe asthma attacks

	Tweet

Giving asthma patients on regular preventive* drugs the same drugs to relieve the symptoms of their condition, rather than conventional reliever** drugs, could reduce their risk of severe attacks and hospitalisations, according to an Article in this week’s issue of The Lancet.

In their trial, Klaus Rabe (Leiden University Medical Centre Leiden, Netherlands) and colleagues studied the effect of using of conventional preventive therapies as reliever therapies for asthma. The investigators assessed the effectiveness and safety of two beta agonists (terbutaline, formoterol) and one inhaled corticosteroid-beta agonist combination (budesonide-formoterol) given as reliever therapies to patients on a preventive drug combination (budesonide-formoterol). After 12 months the investigators found that budesonide-formoterol given as a reliever therapy to people already on the drug combination was the best option for reducing the risk of severe asthma attacks. The rate for severe asthma attack was 37, 29, and 19 per 100 patients per year for terbutaline, formoterol and budesonide-formoterol, respectively.

*Preventive therapy involves two classes of drugs (inhaled corticosteroids and long-acting beta agonists) which control swelling and inflammation of the airways. The drugs prevent the airways from becoming sensitive to environmental triggers, such as house dust mites, and are used to help reduce the risk of asthma attacks.

**Reliever therapies are taken to ease the symptoms of asthma and are essential for treating asthma attacks.

Contact: Dr Klaus F Rabe, Department of Pulmonology C3P, Leiden University Medical Centre, Albinusdreef 2, PO Box 9600, 2333 ZA Leiden, Netherlands. T) +31 71 526 29 50

http://www.thelancet.com

RELATED STORIES:
Drug allergy discovery   Kids on cow farms may have fewer allergies   Researchers identify new regulator in allergic diseases   Low serum adiponectin levels predict future risk for asthma in women   Test to improve peanut allergy diagnosis   Anti-IgE Drug Speeds Up Allergy Therapy   Moms Mistakenly Claim Own Food Allergies   Food Allergy Common in Joint Disorder   Molecule That Offers Hope For Future Allergy Treatments Discovered   Adding Proton Pump Inhibitor to Treat Poorly Controlled Asthma in Children Does Not Improve Symptoms   Accelerated infant growth increases risk of future asthma symptoms in children   Getting a Cat Ups Allergy Risk in Adults

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]